Aileron Therapeutics Data on Stapled Peptide Drugs to Be Presented at ASH Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics announced today that investigators from Aileron and the Dana-Farber Cancer Institute will present data from multiple preclinical studies on stapled peptide drug candidates at the 50th Annual Meeting of the American Society of Hematology in San Francisco, Calif., December 6 to 9, 2008.
MORE ON THIS TOPIC